Marrone Bio Innovations (NASDAQ:MBII) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:30 PM.
Here's what investors need to know about the announcement.
Earnings
Marrone Bio Innovations missed estimated earnings by 100.0%, reporting an EPS of $-0.04 versus an estimate of $-0.02.
Revenue was up $59.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 0.0% increase in the share price the next day.
Here's a look at Marrone Bio Innovations's past performance:
Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
---|---|---|---|---|
EPS Estimate | -0.03 | -0.03 | -0.01 | -0.03 |
EPS Actual | -0.03 | -0.03 | -0.02 | -0.02 |
Revenue Estimate | 10.22M | 10.63M | 15.41M | 11.22M |
Revenue Actual | 10.82M | 9.86M | 12.60M | 11.04M |
To track all earnings releases for Marrone Bio Innovations visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.